(Q37778476)

23 August 2017

1 reference

title

Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders (English)

1 reference

23 August 2017

Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders (English)

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

18 June 2024

0 references

0 references

1 reference

1 reference

1 reference

Ann Gardner

1

1 reference

23 August 2017

Richard G. Boles

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691744

18 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20691744

18 June 2024

publication date

5 August 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0278584610002964?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

https://api.elsevier.com/content/article/PII:S0278584610002964?httpAccept=text/plain

18 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Progress in Neuro-Psychopharmacology & Biological Psychiatry

18 June 2024

published in

1 reference

23 August 2017

volume

35

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

730-743

1 reference

Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients with fibromyalgia

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder

18 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Major depression in 1998: are we providing optimal therapy?

18 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Clinical assessment and treatment of attention deficit hyperactivity disorder in adults

18 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Creatine supplementation reduces plasma levels of pro-inflammatory cytokines and PGE2 after a half-ironman competition

18 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Cell response to oxidative stress induced apoptosis in patients with Leber's hereditary optic neuropathy.

18 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The role of cognitive impairment in general functioning in major depression.

18 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes.

18 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Polymorphisms at cytokine genes may determine the effect of vitamin E on cytokine production in the elderly

18 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

B complex vitamin patterns in geriatric and young adult inpatients with major depression

18 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Low thyroxine levels in female psychiatric inpatients with riboflavin deficiency: implications for folate-dependent methylation

18 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Bipolar II disorder : epidemiology, diagnosis and management

18 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The spectrum of MEFV clinical presentations--is it familial Mediterranean fever only?

18 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine

18 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression

18 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Maternal inheritance in recurrent early-onset depression

18 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache

18 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre

18 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

A high predisposition to depression and anxiety in mothers and other matrilineal relatives of children with presumed maternally inherited mitochondrial disorders

18 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.

18 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Cell death in the nervous system

18 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Comorbidity of migraine and depression: investigating potential etiology and prognosis

18 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency

18 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia.

18 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Effect of electroconvulsive shock on mitochondrial respiratory chain in rat brain.

18 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial inheritance in depression, dysmotility and migraine?

18 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

An update on regional brain volume differences associated with mood disorders

18 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Lower hippocampal volume in patients suffering from depression: a meta-analysis

18 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?

18 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Vitamin E status and quality of life in the elderly: influence of inflammatory processes

18 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Myelin, mitochondria, and autoimmunity: What's the connection?

18 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology

18 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Abnormalities in mitochondrial structure in cells from patients with bipolar disorder

18 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

18 June 2024

Mitochondria

36

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

18 June 2024

Mitochondrial medicine

37

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Comorbid illness in women with chronic fatigue syndrome: a test of the single syndrome hypothesis

18 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Riboflavin inhibits IL-6 expression and p38 activation in islet cells

18 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Riboflavin prophylaxis in pediatric and adolescent migraine

18 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The biochemistry of affective disorders

18 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia.

18 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Pain complaints in depressed inpatients

18 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity

18 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Gray matter volume reduction in the chronic fatigue syndrome.

18 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism

18 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs.

18 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade

18 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial disorders in the nervous system

18 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

18 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

A meta-analysis of cytokines in major depression

18 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Psychiatric comorbidity in 36 adults with mitochondrial cytopathies.

18 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels

18 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Neuropathology of mitochondrial diseases

18 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

18 June 2024

Mitochondriopathies

56

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Drugs interfering with mitochondrial disorders

18 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Plasma cytokines in women with chronic fatigue syndrome

18 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Antidepressant drug effects and depression severity: a patient-level meta-analysis

18 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Whither psychiatric diagnosis

18 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Comorbidity of irritable bowel syndrome in psychiatric patients: a review.

18 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Is a "Mitochondrial Psychiatry" in the Future? A Review

18 June 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial energy depletion in depression with somatization

18 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression

18 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Alterations of rCBF and mitochondrial dysfunction in major depressive disorder: a case report

18 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients

18 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The potential of nutritional therapy.

18 June 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Treatment of mitochondrial cytopathies

18 June 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management

18 June 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression.

18 June 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Role of MHC class I in immune surveillance of mitochondrial DNA integrity

18 June 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome.

18 June 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Cytokines and depression in cases with fibromyalgia

18 June 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The in-depth evaluation of suspected mitochondrial disease

18 June 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes

18 June 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Cerebral folate deficiency and CNS inflammatory markers in Alpers disease.

18 June 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine.

18 June 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis

18 June 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome.

18 June 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies

18 June 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Different tissue distribution of a mitochondrial DNA duplication and the corresponding deletion in a patient with a mild mitochondrial encephalomyopathy: deletion in muscle, duplication in blood

18 June 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

No consistent difference in gray matter volume between individuals with fibromyalgia and age-matched healthy subjects when controlling for affective disorder

18 June 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Autoimmune IDDM in a sporadic MELAS patient with mitochondrial tRNA(Leu(UUR)) mutation.

18 June 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial DNA polymerase-gamma and human disease

18 June 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Family study of fibromyalgia and affective spectrum disorder

18 June 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysis

18 June 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Hypoparathyroidism and insulin-dependent diabetes mellitus in a patient with Kearns-Sayre syndrome harbouring a mitochondrial DNA deletion.

18 June 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Bipolar disorder- and major depression-relevant abstracts from the 2009 9th World Congress of Biological Psychiatry Meeting

18 June 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

An unusual myopathy: speckled muscle fibers due to enlarged mitochondria.

18 June 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Efficacy of DL-alpha lipoic acid against systemic inflammation-induced mice: antioxidant defense system

18 June 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

18 June 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study

18 June 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes.

18 June 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

A marked effect of electroconvulsive stimulation on behavioral aberration of mice with neuron-specific mitochondrial DNA defects

18 June 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder.

18 June 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

A population-based twin study of functional somatic syndromes

18 June 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Effect of long-term in vivo treatment with imipramine on the oxidative energy metabolism in rat brain mitochondria

18 June 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The development of the Feighner criteria: a historical perspective

18 June 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Effects of antidepressants on the production of cytokines

18 June 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors

18 June 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

A microscopic study of kidney tissue in Familial Mediterranean Fever patients

18 June 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Regional grey matter changes in patients with migraine: a voxel-based morphometry study

18 June 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial DNA damage is involved in apoptosis caused by pro-inflammatory cytokines in human OA chondrocytes.

18 June 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Classification of depressive disorders in the DSM-V: proposal for a two-dimension system

18 June 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

IL-6 levels in migraine patients receiving topiramate.

18 June 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Inhibitory mechanisms of highly purified vitamin B2 on the productions of proinflammatory cytokine and NO in endotoxin-induced shock in mice

18 June 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Major depression in adolescent children consecutively diagnosed with mitochondrial disorder

18 June 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype

18 June 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Neuropathology of white matter disease in Leber's hereditary optic neuropathy

18 June 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain?

18 June 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Gender differences in the histopathology of MS?

18 June 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Quantitative assessment of cerebral ventricular volumes in chronic fatigue syndrome.

18 June 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome

18 June 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Is fibromyalgia a muscle disorder?

18 June 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Prevalence and correlates of depression with atypical symptoms in Hong Kong

18 June 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

White matter involvement in mitochondrial diseases

18 June 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

KEARNS-SAYRE SYNDROME WITH MUSCLE MITOCHONDRIAL DNA DELETION

18 June 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Immune activation in patients with irritable bowel syndrome

18 June 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility

18 June 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome.

18 June 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The development of mitochondrial medicine

18 June 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study

18 June 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study.

18 June 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial

18 June 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Immune disturbances during major depression: upregulated expression of interleukin-2 receptors

18 June 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The monocyte-T-lymphocyte hypothesis of major depression

18 June 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Lower serum vitamin E concentrations in major depression

18 June 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

18 June 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness

18 June 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis

18 June 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Prevalence and correlates of bipolar II disorder in major depressive patients at a psychiatric outpatient clinic in Hong Kong.

18 June 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Depression and anxiety in children and adolescents with familial Mediterranean fever

18 June 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Diagnostic approach to mitochondrial disorders: the need for a reliable biomarker.

18 June 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Is multiple sclerosis a mitochondrial disease?

18 June 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Physical Symptoms of Depression

18 June 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue.

18 June 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial disease: mutations and mechanisms.

18 June 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.

18 June 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Depression and type 2 diabetes over the lifespan: a meta-analysis

18 June 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The role of inflammatory markers in the cardioprotective effect of L-carnitine in L-NAME-induced hypertension.

18 June 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Depression and immunity: a role for T cells?

18 June 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Increased oxidative stress suggested by low serum vitamin E concentrations in patients with chronic fatigue syndrome

18 June 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Central nervous system changes in mitochondrial encephalomyopathy: light and electron microscopic study

18 June 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies

18 June 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Chronic fatigue syndrome and mitochondrial dysfunction

18 June 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death

18 June 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants

18 June 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Serotonin, genetic variability, behaviour, and psychiatric disorders--a review

18 June 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Islet cell antibodies in diabetes mellitus associated with a mitochondrial tRNA(Leu(UUR)) gene mutation.

18 June 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

T-cell activation in patients with irritable bowel syndrome

18 June 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Neuropathology in Kearns-Sayre syndrome

18 June 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Low plasma vitamin E levels in major depression: diet or disease?

18 June 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Genetic and functional changes in mitochondria associated with aging

18 June 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Inflammation versus neurodegeneration: consequences for treatment

18 June 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy

18 June 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Magnetic-resonance morphometry in patients with major depression

18 June 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Metabolic testing in the pediatric epilepsy unit

18 June 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

A modern approach to the treatment of mitochondrial disease

18 June 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Cytokines and chronic fatigue syndrome

18 June 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Leber's optic neuropathy associated with disseminated white matter disease: a case report and review

18 June 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Plasma cytokine levels in migraineurs and controls

18 June 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression

18 June 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Clinico-neuropathological study of a Chinese case of familial adult Leigh syndrome

18 June 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder.

18 June 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression

18 June 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression

18 June 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

18 June 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Creatine monohydrate in resistant depression: a preliminary study

18 June 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Depression's forgotten genealogy: notes towards a history of depression

18 June 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The roles of intracellular protein-degradation pathways in neurodegeneration

18 June 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder.

18 June 2024

177

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.

18 June 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems.

18 June 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally

18 June 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The catecholamine hypothesis of affective disorders: a review of supporting evidence

18 June 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Effects of Coenzyme Q10 on TNF-alpha secretion in human and murine monocytic cell lines

18 June 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Influence of Coenzyme Q_{10} on release of pro-inflammatory chemokines in the human monocytic cell line THP-1.

18 June 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Functions of coenzyme Q10 in inflammation and gene expression

18 June 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Striatal grey matter increase in patients suffering from fibromyalgia--a voxel-based morphometry study

18 June 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

18 June 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The role of the carnitine system in myocardial fatty acid oxidation: carnitine deficiency, failing mitochondria and cardiomyopathy

18 June 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial DNA mutations and pathogenesis

18 June 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

New patterns of inheritance in mitochondrial disease

18 June 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation

18 June 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial involvement in psychiatric disorders

18 June 2024

191

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

An international study of the relation between somatic symptoms and depression

18 June 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial disorders: clinical presentation and diagnostic dilemmas

18 June 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Effect of fluoxetine on rat liver mitochondria

18 June 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects.

18 June 2024

195

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

MELAS: clinical phenotype and morphological brain abnormalities

18 June 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial dysfunction and migraine: evidence and hypotheses

18 June 2024

197

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Disorders from perturbations of nuclear-mitochondrial intergenomic cross-talk.

18 June 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Inflammatory cytokines in vascular dysfunction and vascular disease

18 June 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Double-blind placebo-controlled trial of lithium in episodic cluster headache

18 June 2024

200

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Smaller frontal lobe white matter volumes in depressed adolescents.

18 June 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The possible association between affective disorder and partially deleted mitochondrial DNA.

18 June 2024

202

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Cellular changes in the postmortem hippocampus in major depression

18 June 2024

203

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis

18 June 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Typology of common psychiatric syndromes. An empirical study

18 June 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression

18 June 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study

18 June 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies

18 June 2024

208

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Neurodegeneration: a question of balance

18 June 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome

18 June 2024

210

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Antidepressive treatment as a modulator of inflammatory process in patients with heart failure: effects on proinflammatory cytokines and acute phase protein levels.

18 June 2024

211

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Focal cognitive impairment in mitochondrial encephalomyopathies: a neuropsychological and neuroimaging study.

18 June 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Diagnostic and therapeutic trajectory of cluster headache patients in Flanders

18 June 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Gray matter reduction associated with psychopathology and cognitive dysfunction in unipolar depression: a voxel-based morphometry study.

18 June 2024

214

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Intestinal lymphocytic epithelioganglionitis: a unique combination of inflammation in bowel dysmotility: a histopathological and immunohistochemical analysis of 28 cases.

18 June 2024

215

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome

18 June 2024

216

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus

18 June 2024

217

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy

18 June 2024

218

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study

18 June 2024

219

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Effects of tricyclic antidepressant drugs on energy-linked reactions in mitochondria

18 June 2024

220

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Mitochondrial involvement in schizophrenia and other functional psychoses

18 June 2024

221

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults

18 June 2024

222

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

All roads lead to depression: clinically homogeneous, etiologically heterogeneous

18 June 2024

223

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Insulin resistance after oral glucose tolerance testing in patients with major depression.

18 June 2024

224

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Molecular regulation of inflammation and cell death

18 June 2024

225

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Deletions of mitochondrial DNA in Kearns-Sayre syndrome

18 June 2024

226

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia

18 June 2024

228

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Nortriptyline protects mitochondria and reduces cerebral ischemia/hypoxia injury

18 June 2024

229

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

The effect of vitamin E on the treatment of menstrual migraine

18 June 2024

230

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

A simpler definition of major depressive disorder

18 June 2024

231

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

18 June 2024

232

1 reference

https://api.crossref.org/works/10.1016/J.PNPBP.2010.07.030

18 June 2024

Identifiers

1 reference

release_lveuzyljwvbkvkzun5vz6mqgwe

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lveuzyljwvbkvkzun5vz6mqgwe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference